Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMI8T1Y)

Drug Name

PMID24809814C31 Drug Info

Synonyms

4q6r; GTPL8465; BDBM50018282; 30J

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Sphingosine-1-phosphate lyase 1 (SGPL1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LX2931	DMLA8H3	Hereditary acantholytic dermatoses	EC20.2	Phase 2	[2]
LX-2932	DMMRLPF	Autoimmune diabetes	5A10	Terminated	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sphingosine-1-phosphate lyase 1 (SGPL1)	TT618Q2	SGPL1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis. J MedChem. 2014 Jun 26;57(12):5074-84.
2	Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov. 2013 Sep;12(9):688-702.
3	Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J Med Chem. 2010 Dec 23;53(24):8650-62.